Putnam Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$10.5M Sell
2022
Q4
$10.1M Buy
2022
Q3
$7.66M Sell
2022
Q2
$8.47M Buy
2022
Q1
$8.39M Buy
2021
Q4
$8.08M Buy
2021
Q1
Sell
2020
Q4
$6.1M Sell
2020
Q3
$8.66M Buy
2020
Q2
$6.92M Buy